MediPal Holdings Corporation

7459.T
Medical Distribution
2026/10/30 12:01 Updated
Market Cap: $4.5B (¥701.1B)
Stock Price: $21.75 (¥3,425)
Exchange Rate: 1 USD = ¥157.48

Notice Regarding Petition for Permission to Convene an Extraordinary General Meeting of Shareholders by Shareholders

Announced receipt of a petition for permission to convene an extraordinary general meeting of shareholders submitted by shareholders. Proposal No. 1 is dismissal of director(s); Proposal No. 2 is partial amendment to the Articles of Incorporation; Proposal No. 3 is special distribution of surplus; Proposal No. 4 is share buyback as purposes of the meeting.

Importance:
Page Updated: October 26, 2026
IR Disclosure Date: October 26, 2026

Key Figures

  • Dismissal of director Shuichi Watanabe (cases)
  • Partial amendment to Articles of Incorporation (cases)
  • Distribution of surplus (special dividend) (cases)

AI要約

Overview of Petition to Convene Extraordinary General Meeting

This announcement discloses receipt of a court petition for permission to convene an extraordinary general meeting of shareholders submitted by shareholders including Northern Trust Company and Silchester International Investors International Value Equity Trust. The petitioning shareholders have held more than 3% of voting rights for over six months and intend to submit Proposals No. 1–4 for the purpose of convening the extraordinary meeting.

Future Developments and Impact on Investors

Depending on the court's decision and the outcome of the extraordinary meeting, there may be impacts on shareholder composition and voting. In particular, proposals concerning dismissal of directors, amendments to the Articles of Incorporation, and share buybacks are directly linked to corporate management policy. Any new information requiring disclosure will be announced promptly.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

MediPal Holdings Corporation

Company overview · Stock price · Financial data · All IR

View company page →